Mylan Pays $9M To Settle Paclitaxel Patent Suit
Mylan Laboratories has agreed to pay $9 million to Tapestry Pharmaceuticals Inc. and Australia-based Mayne Group Ltd's U.S. unit to settle a patent lawsuit over the cancer treatment paclitaxel....To view the full article, register now.
Already a subscriber? Click here to view full article